Galmed Pharmaceuticals Ltd. — All Filings
351 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
20-F/A
3
424A
424B3
424B4
424B5
6-K
6-K/A
8-A12B
CERTNAS
CORRESP
CT ORDER
D
DRS
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
FWP
POS AM
POS EX
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | — | 0001493152-25-011035 | Mar 20, 2025 | — |
| SCHEDULE 13G/A | — | 0001493152-25-007179 | Feb 18, 2025 | — |
| S-8 | — | 0001493152-25-001231 | Jan 7, 2025 | — |
| EFFECT | — | 9999999995-24-003548 | Nov 21, 2024 | — |
| CORRESP | — | 0001493152-24-046957 | Nov 20, 2024 | — |
| UPLOAD | — | 0000000000-24-012798 | Nov 19, 2024 | — |
| F-3 | — | 0001493152-24-046041 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-118644 | Nov 14, 2024 | — |
| 6-K | — | 0001493152-24-046092 | Nov 14, 2024 | — |
| 6-K | — | 0001493152-24-045809 | Nov 14, 2024 | — |
| CORRESP | — | 0001493152-24-042638 | Oct 28, 2024 | — |
| 424B3 | — | 0001493152-24-042692 | Oct 28, 2024 | — |
| EFFECT | — | 9999999995-24-003299 | Oct 28, 2024 | — |
| UPLOAD | — | 0000000000-24-011986 | Oct 28, 2024 | — |
| F-1 | — | 0001493152-24-041776 | Oct 21, 2024 | — |
| 6-K | — | 0001493152-24-041775 | Oct 21, 2024 | — |
| 6-K | — | 0001493152-24-041130 | Oct 15, 2024 | — |
| 6-K | — | 0001493152-24-038052 | Sep 25, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-016590 | Sep 20, 2024 | — |
| 6-K | — | 0001493152-24-037628 | Sep 20, 2024 | — |
| SC 13G | — | 0001214659-24-016589 | Sep 20, 2024 | — |
| 6-K | — | 0001493152-24-037073 | Sep 19, 2024 | — |
| 6-K | — | 0001493152-24-036393 | Sep 16, 2024 | — |
| CORRESP | — | 0001493152-24-035408 | Sep 9, 2024 | — |
| UPLOAD | — | 0000000000-24-010156 | Sep 9, 2024 | — |
| 424B3 | — | 0001493152-24-035476 | Sep 9, 2024 | — |
| EFFECT | — | 9999999995-24-002767 | Sep 9, 2024 | — |
| 6-K | — | 0001493152-24-034594 | Aug 30, 2024 | — |
| F-1 | — | 0001493152-24-034598 | Aug 30, 2024 | — |
| 6-K | — | 0001493152-24-034198 | Aug 28, 2024 | Jun 30, 2024 |
| 6-K | — | 0001493152-24-034011 | Aug 27, 2024 | — |
| 6-K | — | 0001493152-24-028342 | Jul 18, 2024 | — |
| 6-K | — | 0001493152-24-026889 | Jul 11, 2024 | — |
| 6-K | — | 0001493152-24-022747 | Jun 5, 2024 | — |
| 6-K | — | 0001493152-24-021989 | May 30, 2024 | — |
| 20-F | — | 0001493152-24-013203 | Apr 4, 2024 | Dec 31, 2023 |
| 6-K | — | 0001493152-24-010476 | Mar 19, 2024 | — |
| 6-K | — | 0001493152-24-010019 | Mar 15, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023435 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 5 TO SCHEDULE 13G | 0000921895-24-000447 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001493152-24-005902 | Feb 12, 2024 | — |
| EFFECT | — | 9999999995-23-003480 | Nov 29, 2023 | — |
| 6-K | — | 0001493152-23-042486 | Nov 22, 2023 | — |
| POS AM | — | 0001493152-23-042520 | Nov 22, 2023 | — |
| 6-K | — | 0001493152-23-042127 | Nov 20, 2023 | — |
| POS AM | — | 0001493152-23-039001 | Nov 1, 2023 | — |
| 6-K | — | 0001493152-23-033677 | Sep 26, 2023 | — |
| 6-K | — | 0001493152-23-033458 | Sep 22, 2023 | — |
| 6-K/A | — | 0001493152-23-033277 | Sep 21, 2023 | Sep 20, 2023 |
| 6-K | — | 0001493152-23-033202 | Sep 20, 2023 | — |